DEF 14A

Company

Cardiff Oncology, Inc.

Filed

March 4, 2020

Period of Report

April 16, 2020

Accession Number

0001104659-20-029280

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →